vilazodone (Compound)

Synonyms:Vilazodone, 163521-12-8, 5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide, EMD 515259, 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide, EMD-515259, EMD-68-843, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide, CHEMBL439849, S239O2OOV3, CHEBI:70707, Vilazodone [INN], EMD 68843 (Hydrochloride);SB659746A (Hydrochloride), 5-(4-(4-(5-Cyanoindol-3-yl)butyl)-1-piperazinyl)-2-benzofurancarboxamide, 2-BENZOFURANCARBOXAMIDE, 5-[4-[4-(5-CYANO-1H-INDOL-3-YL)BUTYL]-1-PIPERAZINYL]-, Vilazodone [USAN:INN], vilazodona, vilazodonum, UNII-S239O2OOV3, HSDB 8197, 2-BENZOFURANCARBOXAMIDE, 5-(4-(4-(5-CYANO-1H-INDOL-3-YL)BUTYL)-1-PIPERAZINYL)-, 5-(4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl)benzofuran-2-carboxamide, 5-{4-[4-(5-Cyano-1H-indol-3-yl)butyl]piperazin-1-yl}benzofuran-2-carboxamide, VILAZODONE [MI], Vilazodone (USAN/INN), VILAZODONE [USAN], VILAZODONE [VANDF], VILAZODONE [MART.], VILAZODONE [WHO-DD], SCHEMBL650682, GTPL7427, yl}-1-benzofuran-2-carboxamide, DTXSID80870086, EX-A174, HMS3744C03, HMS3886N05, AMY22748, BCP05225, BDBM50151982, MFCD09838919, s5858, 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine, AKOS015924744, CS-0550, DB06684, PB25213, SB20296, NCGC00371130-03, NCGC00371130-06, AC-25886, AS-73542, HY-14262, EMD 68843;SB 659746A, FT-0675813, D09698, AB01563299_01, EN300-7395058, A900227, L001518, Q408588, 5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-, F0001-2418, 1-[4-(5-cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine, 5-{4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl}benzo-furan-2-carboxamide, 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, 5 -(4-(4-(5 -Cyano-1H-indol-3 -yl)butyl)piperazin-1 -yl)benzofuran-2-carboxamide, 5-[4-[4-(5-CYANOINDOL-3-YL)BUTYL]PIPERAZIN-1-YL]BENZOFURAN-2-CARBOXAMIDE, 5-{4-[4-(5-Cyano-1H-indol-3-yl)-butyl]-piperazin-1-yl}-benzofuran-2-carboxylic acid amide

Pubchem:PUBCHEM:6918314

Id:9f3a3932-3467-5742-b972-9508879349ad

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View vilazodone's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for vilazodone.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with vilazodone.

Results found

Linked to

	Label	Description
	BRD-K58010567-003-01-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 04223 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04223; PubChem_CID:6918314, FILE=drugcentral_drug_04223.json)
	vilazodone (52021844-2088-4e36-8399-5829e04e4869) Collection (Entity type)	Metadatata for vilazodone
	vilazodone negatively regulates AMIGO2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	vilazodone positively regulates AK4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	vilazodone negatively regulates DNAJA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	vilazodone indication Major Depressive Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	vilazodone positively regulates TM4SF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	vilazodone negatively regulates OXTR Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	vilazodone positively regulates CDC20 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS